Literature DB >> 9860155

Trends in aspirin, paracetamol and non-steroidal anti-inflammatory drug use in children between 1981 and 1992 in France.

P Maison1, D Guillemot, F Vauzelle-Kervroëdan, B Balkau, C Sermet, N Thibult, E Eschwège.   

Abstract

OBJECTIVE: Antipyretic/analgesic drugs (AADs) are among the most commonly used drugs in children. Their efficacy and adverse effects have often been debated and new AADs have been introduced over the past few years. The aim of this study was to assess the characteristics of the use of AADs in children in France, and their trends.
METHODS: Two surveys on household health care consumption were undertaken in France, in 1981 and in 1992. They included 5060 and 4841 children, respectively. The AADs studied were aspirin, paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs).
RESULTS: The proportion of children exposed to AADs increased significantly between 1981 and 1992 (+28% in 11 years). Among them, the percentage of subjects treated with aspirin decreased (-27%). In contrast, the percentage increased for paracetamol (+ 19%) and for NSAIDs (+179%). Aspirin was the AAD most used in 1981 (57.4%) and it was replaced by paracetamol in 1992 (71.6%). Nasopharyngitis was the main reason for AAD prescription under the age of 11 years; for older children it was influenza-like syndrome, irrespective of the study year. A change in AAD choice occurred in nasopharyngitis, acute bronchitis and influenza-like syndrome irrespective of the age group, and in otitis/sinusitis between 4 and 10 years. In all these cases aspirin prescription decreased, in contrast with paracetamol and NSAIDs. Self-medication of AAD was uncommon (8.3% for aspirin and 10.3% for paracetamol in 1992) and decreased (-29% and -33%). It was used principally for nasopharyngitis, influenza-like syndrome and pain.
CONCLUSION: The consumption of AADs in children is high and is increasing. Paracetamol and NSAIDs tend to replace aspirin prescription in children and physicians have played the main role in this change.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860155     DOI: 10.1007/s002280050530

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Drug use of children in the community assessed through pharmacy dispensing data.

Authors:  E Schirm; P van den Berg; H Gebben; P Sauer; L De Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

Review 2.  Paracetamol for treating fever in children.

Authors:  M Meremikwu; A Oyo-Ita
Journal:  Cochrane Database Syst Rev       Date:  2002

3.  Association between parental attitudes and self-medication of their children.

Authors:  Sanna Siponen; Riitta Ahonen; Vesa Kiviniemi; Katri Hämeen-Anttila
Journal:  Int J Clin Pharm       Date:  2012-10-26

Review 4.  Aspirin and Reye syndrome: a review of the evidence.

Authors:  Karsten Schrör
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 5.  Nonsteroidal anti-inflammatory drugs for postoperative pain: a focus on children.

Authors:  Hannu Kokki
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

6.  Parent's knowledge and management of their children's ailments in Malaysia.

Authors:  Omar T Dawood; Mohamed I M Ibrahim; Subish Palaian
Journal:  Pharm Pract (Granada)       Date:  2010-03-15

7.  Parental Experience of Potential Adverse Drug Reactions Related to Their Oral Administration of Antipyretic Analgesic Medicines in Children in Saudi Arabia.

Authors:  Mansour Tobaiqy; Katie MacLure; Mansoor Radwi; Ashwaq M Almalki; Ahmed H Alhasan; Maya Tannoury; Zouhair Attieh
Journal:  Curr Ther Res Clin Exp       Date:  2020-06-20

8.  Dosing variability in prescriptions of acetaminophen to children: comparisons between pediatricians, family physicians and otolaryngologists.

Authors:  Yueh-Ching Chou; Shin-Yi Lin; Tzeng-Ji Chen; Shu-Chiung Chiang; Mei-Jy Jeng; Li-Fang Chou
Journal:  BMC Pediatr       Date:  2013-04-24       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.